ACE2 and COVID-19: The study found that epithelial cells of COVID-19 patients showed an average three-fold increase in expression of the SARS-CoV-2 entry receptor ACE2, and signal transducer and activator of transcription 1 (STAT1), a central transcription factor of the interferon response, was among the top predictors for ACE2 expression.